ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 78 filers reported holding ITEOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,368,986 | -17.3% | 4,417,259 | 0.0% | 0.95% | -13.8% |
| Q2 2023 | $58,484,509 | -2.7% | 4,417,259 | 0.0% | 1.10% | -18.9% |
| Q1 2023 | $60,118,895 | -30.3% | 4,417,259 | 0.0% | 1.36% | -22.2% |
| Q4 2022 | $86,269,068 | +2.5% | 4,417,259 | 0.0% | 1.75% | -2.5% |
| Q3 2022 | $84,149,000 | -7.5% | 4,417,259 | 0.0% | 1.80% | -26.0% |
| Q2 2022 | $90,996,000 | -36.0% | 4,417,259 | 0.0% | 2.43% | -21.8% |
| Q1 2022 | $142,147,000 | -30.9% | 4,417,259 | 0.0% | 3.10% | -14.5% |
| Q4 2021 | $205,668,000 | +72.4% | 4,417,259 | 0.0% | 3.63% | +119.4% |
| Q3 2021 | $119,266,000 | +5.3% | 4,417,259 | 0.0% | 1.65% | -9.1% |
| Q2 2021 | $113,303,000 | -25.0% | 4,417,259 | +0.0% | 1.82% | -20.1% |
| Q1 2021 | $150,982,000 | +1.1% | 4,417,258 | 0.0% | 2.28% | +9.1% |
| Q4 2020 | $149,392,000 | +37.1% | 4,417,258 | 0.0% | 2.09% | +4.8% |
| Q3 2020 | $108,974,000 | – | 4,417,258 | – | 1.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |